Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

View:
Post by pelaboost on Dec 13, 2023 3:21pm

de G

I liked de G. He struck me as competent and a decent sort.

Let's hope his job is done. I wish him well.
Comment by canadafan on Dec 13, 2023 3:43pm
You do not need a business development executive for a buyout. That could be part of a paridim shift. Other possibilities? He retired. Part if year end decision. or fired, part of well needed reorganization. or? Many options. Speaking if options. Looks like Matt took his 350,000 shares. Thungs are happening as they need to happen. We can only hope for the best. BTW his name is still on investor ...more  
Comment by pelaboost on Dec 13, 2023 4:01pm
@canadafan. I really did not intend to develop de G's exit. I just wanted to wish him well. But as you have opened it up, I am leaning to thinking that he is leaving on a high note. He is a very capable guy, and I am thinking he did in fact get his part of the job done. If we do get good news rest assured he had a hand in. Now, thank you for reporting on the options of MC. I, like a few ...more  
Comment by jh1970 on Dec 13, 2023 4:17pm
Filed 2023-12-13 15:03   Tx date 2023-12-08 $ONC Oncolytics Biotech Inc. Heineman, Thomas 5 - Senior Officer of Issuer Direct Ownership Rights Restricted Share Units 56 - Grant of rights +62,100 vol 86,000   Filed 2023-12-13 15:02  ...more  
Comment by inthno on Dec 13, 2023 4:07pm
I could be wrong but from sedi this is not showing that he took 350,000 shares, instead it is showing that he was awarded another 350,000 options unless I am reading this wrong. Filed 2023-12-13 14:54 Tx date 2023-12-08 $ONC Oncolytics Biotech Inc. Coffey, Matthew 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership Rights Restricted Share Units 56 - Grant of rights +93,800 vol ...more  
Comment by ScootsMcgoots on Dec 13, 2023 4:23pm
Right now it's just showing new options were granted. Not showing what they did with the old ones. Just a matter of hours before we know. Good work today digging that up about Andrew. Really incredible sleuthing!
Comment by ScootsMcgoots on Dec 13, 2023 4:36pm
Just thinking this through. Andrew De G left a mere week before holiday options were granted. He got no options in this last grant according to ceo.ca. This wasn't a friendly departure. He was fired. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities